Free Trial

Moleculin Biotech (MBRX) Earnings Date, Estimates & Call Transcripts

$4.35
+0.40 (+10.13%)
(As of 07/12/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 9Estimated
Actual EPS
(May. 10)
-$2.02 Beat By $1.57
Consensus EPS
(May. 10)
-$3.59
Skip Charts & View Estimated and Actual Earnings Data

MBRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MBRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Moleculin Biotech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($3.59)($3.59)($3.59)
Q2 20241($2.10)($2.10)($2.10)
Q3 20241($1.46)($1.46)($1.46)
Q4 20241($1.53)($1.53)($1.53)
FY 20244($8.68)($8.68)($8.68)

MBRX Earnings Date and Information

Moleculin Biotech last issued its earnings results on May 10th, 2024. The reported ($2.02) EPS for the quarter, topping the consensus estimate of ($3.59) by $1.57. Moleculin Biotech has generated $0.00 earnings per share over the last year. Earnings for Moleculin Biotech are expected to grow in the coming year, from ($8.79) to ($5.28) per share. Moleculin Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off prior year's report dates.

Moleculin Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/9/2024
(Estimated)
------- 
5/10/2024Q1 2024($3.59)($2.02)+$1.57($2.02)--
11/13/2023Q3 2023($3.15)($2.85)+$0.30($0.19)--
8/11/2023Q2 2023($4.20)($3.00)+$1.20($0.20)--
5/11/2023Q1 2023($3.75)($4.20)($0.45)($0.28)--
3/22/2023Q4 2022($4.20)($3.60)+$0.60($0.24)--
11/10/2022Q3 2022($4.05)($4.50)($0.45)($0.30)--
8/15/2022Q2 2022($3.75)($3.60)+$0.15($0.24)--
5/11/2022Q1 2022($3.15)($3.60)($0.45)($0.24)--
3/25/2022Q4 2021($3.15)($2.55)+$0.60($0.25)--
11/11/2021Q3($3.00)($2.25)+$0.75($0.15)--
8/10/2021Q2($2.8050)($2.25)+$0.5550($0.23)--
5/11/2021Q1 2021($3.45)($3.00)+$0.45($0.20)--
3/23/2021Q4 2020($8.70)($3.90)+$4.80---
11/19/2020Q3($8.37)($5.40)+$2.97($0.06)--  
8/12/2020Q2 2020($8.10)($15.30)($7.20)$0.01--  
5/11/2020Q1 2020($9.00)($9.00)-($0.18)--
3/19/2020Q4 2019($9.90)($7.20)+$2.70($0.08)--
11/12/2019Q3($7.65)($8.10)($0.45)($0.09)--  
8/16/2019Q2($9.45)($2.70)+$6.75($0.15)--  

Moleculin Biotech Earnings - Frequently Asked Questions

When is Moleculin Biotech's earnings date?

Moleculin Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off last year's report dates. Learn more on MBRX's earnings history.

Did Moleculin Biotech beat their earnings estimates last quarter?

In the previous quarter, Moleculin Biotech (NASDAQ:MBRX) reported ($2.02) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.59) by $1.57. Learn more on analysts' earnings estimate vs. MBRX's actual earnings.

How much profit does Moleculin Biotech generate each year?

Moleculin Biotech (NASDAQ:MBRX) has a recorded net income of -$29.77 million. MBRX has generated $0.00 earnings per share over the last four quarters.

What is Moleculin Biotech's EPS forecast for next year?

Moleculin Biotech's earnings are expected to grow from ($8.79) per share to ($5.28) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:MBRX) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners